Portfolio Management

Expanding Into Asia-Pacific: Life sciences opportunities and strategies for success
Objective :

Management of the client’s Infectious Disease portfolio to ascertain the best course of action for the future clinical and commercial development of therapeutics under the said portfolio, leading to increased ROI

Problem Statement:

A small-Pharma client based in Israel involved DelveInsight to manage their portfolio of candidates indicated for various infectious diseases. The client provided DelveInsight with the task of assessing the best strategic direction for each asset through extensive market research analysis, for development for US and EU regions.

Our Methodology:
  • Infectious Disease Market Assessment
  • Opportunity Assessment for each candidate
  • Unmet Need Analysis of Patients in regions of the client’s interest
  • Market Valuation and Future Trend Overview
Results:
  • Detailed landscaping of the arena in the regions of client’s interest
  • Asset prioritization to segregate assets for development or divestiture
  • Opportunity Assessment to allocate resources for future development
  • Market Assessment to understand Future Market Share

Related Insights

Product Assessment
Product Assessment

A large pharma client was working to develop their cyclophosphamide API and FD, and was interested to assess competitive products [...]

View Case
Competitive Intelligence
Competitive Intelligence

A large client based in Europe involved DelveInsight to assist in assessing counter-intelligence strategies for them, after evaluation of their level of leakiness among middle and high-level employees. [...]

View Case
R&D Analysis
R&D Analysis

A mid-Pharma client based in India involved DelveInsight to assist in gathering and analyzing congress abstracts and literature review from various congresses for Parkinson’s disease. [...]

View Case

Fill the form to download the case study

I consent to DelveInsight gathering details provided via this form. Check our Privacy Policy to know more.